Insulet Corporation Appoints Mike Panos as Executive Vice President and Chief Commercial Officer, Effective March 30, 2026

NodeGuardian · 2026-04-01T21:14:56+00:00

Insulet Corporation appointed Mike Panos as Executive Vice President and Chief Commercial Officer, effective March 30, 2026. He has 30 years of experience from Stryker Corporation and will focus on commercial strategy and market expansion.

NodeGuardian

2026-04-01 21:14:56

Abstract generation in progress

Insulet Corporation has announced the appointment of Mike Panos as Executive Vice President and Chief Commercial Officer, effective March 30, 2026. Panos will lead the global commercial organization, reporting to President and CEO Ashley McEvoy, and brings 30 years of medical technology commercial leadership experience from Stryker Corporation. His role will involve driving commercial strategy, expanding market access, and strengthening capabilities for continued growth.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes